Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP161653.RAfuWwYwoIswcswukhSB05oHJ40l56IqxMvu1QNzL2njQ130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP161653.RAfuWwYwoIswcswukhSB05oHJ40l56IqxMvu1QNzL2njQ130_provenance.
• NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_provenance.
• NP806073.RAijeGU7IO8QacITIgow2o_CduaSUH_MI7laphFjl4rMY130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806073.RAijeGU7IO8QacITIgow2o_CduaSUH_MI7laphFjl4rMY130_provenance.
• NP294746.RAFmetauCCeyYCdoYU_35egFgVnCh9dtyMhXRIRSDW5kU130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294746.RAFmetauCCeyYCdoYU_35egFgVnCh9dtyMhXRIRSDW5kU130_provenance.
• NP476635.RAdrLN4nWcVRYj4buWt-uswmymHAnG3AqFugfpSJ9EYiI130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476635.RAdrLN4nWcVRYj4buWt-uswmymHAnG3AqFugfpSJ9EYiI130_provenance.
• NP478691.RAYCJjqYzHH-8tIX04f-VIdo-PEUDEzQd1ynUyJJLCeQE130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478691.RAYCJjqYzHH-8tIX04f-VIdo-PEUDEzQd1ynUyJJLCeQE130_provenance.
• assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
• NP1024931.RAWuWZacCfhnSqtdAtUuZBayfK5_deveoSgNDP9m-Xc2I130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024931.RAWuWZacCfhnSqtdAtUuZBayfK5_deveoSgNDP9m-Xc2I130_provenance.
• NP1024929.RAsVPN0HgWgDj7b4k8zovXf1y-4r_FKAznoGVq1XqyBb8130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024929.RAsVPN0HgWgDj7b4k8zovXf1y-4r_FKAznoGVq1XqyBb8130_provenance.
• NP477827.RAM2y7Jnlo83PW5X5hD13e_LUr738oRhXrLGxs0LWiKYE130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477827.RAM2y7Jnlo83PW5X5hD13e_LUr738oRhXrLGxs0LWiKYE130_provenance.
• NP478579.RAPY9gMWHMchN_oaoELFcxO8RwERsjOjtewHXwUR8qK6Q130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478579.RAPY9gMWHMchN_oaoELFcxO8RwERsjOjtewHXwUR8qK6Q130_provenance.
• NP1024927.RAHm76QPPdJXNOUVCw8vsfedAK0Oakm_qWFbU9MyCZteI130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024927.RAHm76QPPdJXNOUVCw8vsfedAK0Oakm_qWFbU9MyCZteI130_provenance.